BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34061847)

  • 21. Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
    Na R; Labbate C; Yu H; Shi Z; Fantus RJ; Wang CH; Andriole GL; Isaacs WB; Zheng SL; Helfand BT; Xu J
    JAMA Netw Open; 2019 Dec; 2(12):e1918145. PubMed ID: 31880795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations.
    Grönberg H; Wiklund F; Damber JE
    Cancer; 1999 Aug; 86(3):477-83. PubMed ID: 10430256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat-ectomy. A nationwide population-based study.
    Scilipoti P; Liedberg F; Garmo H; Wilberg Orrason A; Stattin P; Westerberg M
    Scand J Urol; 2024 May; 59():98-103. PubMed ID: 38738332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland.
    Matikaine MP; Pukkala E; Schleutker J; Tammela TL; Koivisto P; Sankila R; Kallioniemi OP
    Cancer Causes Control; 2001 Apr; 12(3):223-30. PubMed ID: 11405327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study.
    Bratt O; Kristoffersson U; Lundgren R; Olsson H
    Eur J Cancer; 1997 Nov; 33(13):2237-40. PubMed ID: 9470812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.
    Cannon-Albright LA; Carr SR; Akerley W
    J Thorac Oncol; 2019 Jul; 14(7):1184-1191. PubMed ID: 31075544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.
    Darst BF; Wan P; Sheng X; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Stevens VL; Berndt SI; Huff CD; Strom SS; Park JY; Zheng W; Ostrander EA; Walsh PC; Srivastava S; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Yeager M; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Kote-Jarai Z; Govindasami K; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach R; Gundell SM; Pooler L; Xia L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Eeles RA; Brureau L; Chanock SJ; Watya S; Stanford JL; Mandal D; Isaacs WB; Cooney K; Blot WJ; Conti DV; Haiman CA
    Eur Urol; 2020 Sep; 78(3):316-320. PubMed ID: 32409115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Causes of death in men with localized prostate cancer: a nationwide, population-based study.
    Van Hemelrijck M; Folkvaljon Y; Adolfsson J; Akre O; Holmberg L; Garmo H; Stattin P
    BJU Int; 2016 Mar; 117(3):507-14. PubMed ID: 25604807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
    Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
    Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial colorectal cancer risk in half siblings and siblings: nationwide cohort study.
    Tian Y; Kharazmi E; Sundquist K; Sundquist J; Brenner H; Fallah M
    BMJ; 2019 Mar; 364():l803. PubMed ID: 30872356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.
    Carlsson S; Assel M; Ulmert D; Gerdtsson A; Hugosson J; Vickers A; Lilja H
    Eur Urol; 2017 Jan; 71(1):46-52. PubMed ID: 27084245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study.
    Orrason AW; Garmo H; Styrke J; Dickman PW; Stattin P
    Am J Epidemiol; 2021 Oct; 190(10):2053-2063. PubMed ID: 34007984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.
    Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ
    Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
    Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
    Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate cancer risk prediction based on complete prostate cancer family history.
    Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
    Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.
    Sabol RA; Ledet EM; Jaeger E; Hatton W; Moses M; Lankford A; Zaheria A; Barata P; Layton JL; Lewis BE; Sartor O
    Prostate; 2021 May; 81(7):427-432. PubMed ID: 33760238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial risk and familial survival in prostate cancer.
    Hemminki K
    World J Urol; 2012 Apr; 30(2):143-8. PubMed ID: 22116601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study.
    Bratt O; Drevin L; Akre O; Garmo H; Stattin P
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27400876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative Risks for Lethal Prostate Cancer Based on Complete Family History of Prostate Cancer Death.
    Albright FS; Stephenson RA; Agarwal N; Cannon-Albright LA
    Prostate; 2017 Jan; 77(1):41-48. PubMed ID: 27527734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.